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Supplementary Figure 1. RNAIII and SprD RNAs do not control Sbi expression at the 
RNA level. (A) Quantification by PCR of the sbi mRNA levels at the E phase (OD600nm: 3) in 
wild-type (wt) and in ∆sprD, ∆rnaIII and ∆sprD-∆rnaIII S. aureus HG001 isogenic deletion 
strains. Both, SprD and RNAIII, are expressed at this growth point (Figures 1B and 1D). The 
sbi mRNA expression levels of the three mutants were calculated relative to the value measured 
for the wt strain. The error bars indicate the mean values derived from three independent 
experiments. For the quantitative real-time PCR (qRT–PCR), cDNAs were prepared using a 
High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). qRT–PCR experiments 
were performed using RealMasterMix SYBR ROX (5 PRIME) with the primers listed in 
Supplementary Table 2. Three independent experiments were performed, with independent 
RNA purifications. The hu and ssrA genes were used for normalization. (B) Evaluation of the 
half-life of sbi mRNA in the strains HG001 (WT) and HG001∆sprD∆rnaIII (∆sprD∆rnaIII). 
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sbi mRNA half-life was measured in the presence of rifampicin (200 mg/ml) at mid-exponential 
growth phase (after 4h of growth). qRT-PCR conditions were as for panel (A). The half-life 
was given as the time where 50% of the RNA was degraded. Four independent experiments 
were performed, with independent RNA purifications. 
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Supplementary Figure 2. RNAIII 5’ and 3’ domains interact at distinct sites on sbi mRNA. (A) 
Native gel retardation assays of labeled RNAIII with increasing amounts of unlabeled sbi1-179 mRNA 
(0.1, 0.2, 0.5, 1 and 2 µM). The asterisk indicates the sbi mRNA/RNAIII molar ratio used to perform 
the competition assays with a 1000-fold molar excess of total yeast tRNAs. (B) Deletion mutants 
constructed from and presented on the RNAIII secondary structure. ‘middle RNAIII’ is gray and 
corresponds to stem-loops 3-11 (grey), 5’RNAIII is blue and contains stem-loops 1-2 with half B and 
half C, and 3’RNAIII is red and encloses stem-loops 11-14. (C) Both its 5’- and 3’-domains are 
involved in RNAIII’s interaction with sbi mRNA. Native gel retardation assays were used to show 
complex formation between labeled sbi mRNA and: full-length RNAIII (RNAIII; 0.1, 0.5 and 2 µM, 
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left to right); 3’-domain (3’RNAIII; 0.1, 0.5 and 2 µM,); central domain (Middle RNAIII; 0.1, 0.5 and 
2 µM,); or 5’-domain (5’RNAIII; 0.1, 0.2, 0.5, 1 and 2.5 µM). (D) Schematic representation and 
location of the sbi1-91 and sbi84-179 constructs on sbi mRNA. Only sbi1-91 contains the translation 
initiation signals. (E) RNAIII 3’-domain binds at the 5’-end of the sbi mRNA, while the 5’-domain of 
RNAIII interacts with the 3’-end of the sbi mRNA fragment. Native gel retardation assays were used to 
show complex formation between purified labeled 1-91 nts sbi mRNA (sbi1-91*) or 84-179 nts sbi 
mRNA (sbi84-179*) constructs with increasing amounts (0.2, 1.0 and 2.5 µM) of unlabeled full-length 
RNAIII, 5’-RNAIII or 3’-RNAIII. 
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Supplementary Figure 3. The 5’-secondary structure of sbi mRNA. Secondary structure model of 
the sbi mRNA 5’-end (nts 1-238) of S. aureus strain N315. Solution probing data provided 
experimental support for the proposed structure. A conformation of only 62 nucleotides from the sbi 
mRNA 5’-end was already reported (Chabelskaya et al, 2010). Since the RNAIII-sbi mRNA 
interactions are extensive and complicated, the probing data were collected for a longer sbi mRNA 
fragment. Triangles indicate V1 cuts; arrows capped by circles indicate S1 cuts. Shown are the 
structural changes induced by sbi mRNA binding of 5’RNAIII (blue), 3’RNAIII (red), and full-length 
RNAIII. The boxed nucleotides are the sbi mRNA TIS. 
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Supplementary Figure 4. Structural analysis of the conformational changes within the structure 
of RNAIII when in complex with sbi mRNA. (A) Conformational changes induced by the sbi mRNA 
on 5’RNAIII (left) or 3’RNAIII (right), detected by structural probes in solution. Shown are 
autoradiograms of the cleavage products of 5'-labeled RNAIII fragments by Nuclease S1 and RNase 
V1 in the presence (+) or absence (–) of sbi mRNA. Track C, incubation controls; track GL, RNase T1 
hydrolysis ladders; track AL, RNase U2 hydrolysis ladders; track AH, alkaline hydrolysis ladders. (B) 
The RNAIII secondary structure (Benito et al. 2000) supported by the probing data presented in this 
report, showing the structural changes induced by complex formation with sbi mRNA. Triangles 
indicate V1 cuts; arrows capped by circles indicate S1 cuts. The structural changes induced by sbi 
mRNA binding with RNAIII are red, and the outlined nucleotides are those that are subjected to 
reactivity changes. Complex formation between sbi mRNA and 5’RNAIII induced structural changes 
located 22-44 nucleotides from the RNAIII 5’-end (part of stems B and C and H2). Binding between 
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the sbi mRNA and 3’RNAIII induced structural changes located at loop 11, stem-loop 12, part of stem 
13, and at SS.  
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Supplementary Figure 5. A RNAIII-∆BC mutant is still able for governance of Sbi protein expression 
in vivo. The expression of protein Sbi at the exponential phase of growth in strain HG001∆rnaIII 
complemented with pCN38RNAIII (RNAIII) or pCN38RNAIII-∆BC (RNAIII-∆BC). Total protein 
amounts loaded and stained by Coomassie are shown. The lower panel depicts the Northern blot 
expression levels of RNAIII and mutant. 
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Supplementary Figure 6. Internal protein controls. Coomassie staining of the samples presented in 
Figures 1A (A), 6B (B) and 6C (C). 
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Supplementary Figure 7. Proposed pairings between the sbi mRNA translation initiation signals, 
SprD, and RNAIII. Pairings are based on the experimental data provided in this report and from our 
previous work (18). The structural domains of the two RNAs are indicated and the gray highlighting 
corresponds to the sbi mRNA TIS. 
  
 
12 
Supplementary Table 1. Strains used in and constructed for this study 
E. coli 
References 
DH5α 
F- φ80 ∆lacZ ∆M15 ∆(lacZA-argF)U169 deoR 
recA1 endA1 hsdR17 (rK- mK-) phoA supE44 λ- 
thi-1 gyrA96 relA1 
3 
S. aureus 
 
RN4220 Restriction-defective derivative of 8325-4 4 
HG001 rsbU restored strain 8325, lysogenic for phages φ11, φ12, and φ13 5 
HG001 ∆rnaIIIa HG001 deleted for rnaIII by homologous 
recombination 2 
HG001 ∆rnaIII HG001 deleted for rnaIII; rnaIII::cat86 This work 
HG001 ∆sprD HG001 deleted for sprD This work 
HG001 ∆sprD∆rnaIII HG001 deleted for sprD and rnaIII; rnaIII::cat86 This work  
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Supplementary Table 2. DNA primers used in this study. 
DNAs Sequences Purposes 
Anti1640 GGCGCTCCTTGAAAACGCCC SprD Northern 
NB3’RNAIII TCAAATAATGATAAATCGATGTTGT RNAIII Northern 
T7RNAIIIfor TAATACGACTCACTATAGGGCCTAGATCACAGAGATGT 
RNAIII  transcription 
T7RNAIIIrev CAAAAGGCCGCGAGCTTGGGA 
SBIforTR TAATACGACTCACTATAGGCATACAATAAATTTAATATGTAA 
sbi mRNA transcription, 
toeprint SBIrevTR179 GTTGTTTTGAGTTGTTTGGTGCT 
SbiT7rev238  
 
TCTGTGATACCTTTTAGATGTA 
T7rev_Sbi_5’90 GTAATTGTTGCTGCCCCAACT sbi1-91 transcription 
SBIT7delta84 TAATACGACTCACTATAGGCAATTACTTTAGCTACAAT sbi84-179 transcription 
RNAIII1_2rev CTTCCTTAATTAAGATAAAAATTC 5’RNAIII transcription 
RNAIII11_14for TAATACGACTCACTATAGGGCTAGCATGTAAGCTATCGTAAACAACA 3’RNAIII transcription 
RNAIII2_10for TAATACGACTCACTATAGGGGTAATTAAGGAAGGAGTGATTTCA 
‘middle’ RNAIII 
transcription 
RNAIII3_11rev GATAGCTTACATGCTAGAAATAAT 
Revdelta14 CAGTTATTTTTTCAATCTATTT RNAIII-∆SS&14 mutation, for in vitro transcription 
D14_mut_tb14rev CAAAAGGCCGCGAGCCTTTCCTTTGCTCACGACCATACTTATTA RNAIII-lutL14 mutation, for in vitro transcription 
D14ssfor ATAGATTGAAAAAATAACTGTAAAAAATAATAAGTATGGTCGTGA RNAIII-∆SS mutation, for 
in vitro transcription and in 
vivo expression D14ssrev TCACGACCATACTTATTATTTTTTACAGTTATTTTTTCAATCTAT 
RNAIIIdeltaBC 
 
TAATACGACTCACTATAGGGCCTAGATCACAGAGATGTGATGGTTAAGAATTTTTATC
TTAATT 
 
‘RNAIII-BC’ RNAIII 
transcription 
rnaIIIDelta_11_12_for AATTATCATTACAGATAATTATAAACAACATCTTTTTTTCATAATTAATAACA 
 
‘RNAIII-11,12’ RNAIII 
transcription 
rnaIIIDelta_11_12_rev TGTTATTAATTATGAAAAAAAGATGTTGTTTATAATTATCTGTAATGATAATT 
 
RNAIII3EcoRI AGTAGGAATTCCAACGCGAAAATATACCTGTAT RNAIII plasmid 
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RNAIII5PstI AGTTCTGCAGATACGTGGCAAACTGGTCAAT 
new3’11_12_13_14_for AGCATGTTTTAATATAACTAGTTATCATTACAGATAATTATT 
in vivo 3’RNAIII expression 
new3’11_12_13_14_rev AATAATTATCTGTAATGATAACTAGTTATATTAAAACATGCT 
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